RxDoctor Payments Data

Csaba Gajdos, MD

Surgical Oncology · Stamford, CTNPI 1710192083

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Intuitive Surgical at 52.0% of the total. Reporting peaked in 2019 at $1,756 and has fallen 82.7% since, to $303 in 2025.

$4,925in general payments, 2019–2025

Across 39 payments — averaging $126.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Merck$2K
  • Medtronic$268
  • Covidien LP$200
  • Sirtex Medical Inc$158
  • Astellas Pharma US Inc$120
  • plus $120 from 5 others

What the payments were for

  • Consulting fees$1,50030%
  • Travel & lodging$2,10643%
  • Food & beverage$1,31027%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,925 in reported general payments places this provider in the 75th percentile of 30 surgical oncology providers in Connecticut.

See all surgical oncology providers in Connecticut

Medicare billing

Part B allowed, 2024
$33,695
Medicare patients
52
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →